Cargando…
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment
The greatest obstacle to a cure for HIV is the provirus that integrates into the genome of the infected cell and persists despite antiretroviral therapy. A “shock and kill” approach has been proposed as a strategy for an HIV cure whereby drugs and compounds referred to as latency-reversing agents (L...
Autores principales: | White, Cory H., Beliakova-Bethell, Nadejda, Lada, Steven M., Breen, Michael S., Hurst, Tara P., Spina, Celsa A., Richman, Douglas D., Frater, John, Magiorkinis, Gkikas, Woelk, Christopher H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906534/ https://www.ncbi.nlm.nih.gov/pubmed/29706951 http://dx.doi.org/10.3389/fimmu.2018.00603 |
Ejemplares similares
-
Epigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs)
por: Hurst, Tara P., et al.
Publicado: (2017) -
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model
por: White, Cory H., et al.
Publicado: (2016) -
Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency
por: Hurst, Tara, et al.
Publicado: (2016) -
The decline of human endogenous retroviruses: extinction and survival
por: Magiorkinis, Gkikas, et al.
Publicado: (2015) -
Long non-coding RNAs and latent HIV – A search for novel targets for latency reversal
por: Trypsteen, Wim, et al.
Publicado: (2019)